EUVIMEDEUVIMED entdecken
Crossref

Albuminuria testing rates in people with diabetes, Victoria, 2022–2024: analysis of a pathology dataset

Samuel F McCormick iD, Glenn M Ward, Christina M Trambas, Richard J MacIsaac

Internal Medicine Journal · 2026

DOI: 10.1111/imj.70348 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Internal Medicine Journal, 2026. Verfasst von Samuel F McCormick und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology & Diabetes, St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Albuminuria, Diabetic Nephropathies, Diabetes Mellitus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Urinary albumin measurement is vital in the screening and monitoring of diabetic kidney disease, but is substantially under‐performed. We analysed pathology data from St Vincent's Pathology, Melbourne, between 2022 and 2024 to assess urinary albumin‐creatinine ratio (ACR) testing rates in diabetes. Among 19 198 adults, only 23.7% had ≥1 ACR value recorded. Testing increased with risk markers (age, male sex, high hemoglobin A 1c , low estimated glomerular filtration rate) but remained low, underscoring significant screening and monitoring gaps.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlbuminuriaDiabetic NephropathiesDiabetes MellitusHumansMaleFemaleVictoriaMiddle AgedAgedCreatinineAdultGlomerular Filtration RateMass Screening

Stichwörter der Autor:innen

albuminuriadiabetesdiabetic nephropathiesrenal insufficiency

Substanzen

Creatinine

Autor:innen und Institutionen

  • Department of Endocrinology & Diabetes, St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia.
  • Department of Clinical Biochemistry, St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia.
  • Department of Medicine St Vincent's Hospital Melbourne, University of Melbourne, Melbourne, Victoria, Australia.
  • Australian Centre for Accelerating Diabetes Innovations, School of Medicine, University of Melbourne, Melbourne, Victoria, Australia.

ORCID-Profile: Samuel F McCormick

Zitieren

APA

McCormick, S. F., Ward, G. M., Trambas, C. M., & MacIsaac, R. J. (2026). Albuminuria testing rates in people with diabetes, Victoria, 2022–2024: analysis of a pathology dataset. Internal Medicine Journal. https://doi.org/10.1111/imj.70348

Vancouver

McCormick SF, Ward GM, Trambas CM, MacIsaac RJ. Albuminuria testing rates in people with diabetes, Victoria, 2022–2024: analysis of a pathology dataset. Internal Medicine Journal. 2026. doi:10.1111/imj.70348

BibTeX
@article{McCormick2026,
  author = {McCormick, Samuel F and Ward, Glenn M and Trambas, Christina M and MacIsaac, Richard J},
  title = {Albuminuria testing rates in people with diabetes, Victoria, 2022–2024: analysis of a pathology dataset},
  journal = {Internal Medicine Journal},
  year = {2026},
  doi = {10.1111/imj.70348}
}
Kostenlos starten →